Hereditary Angioedema (HAE) is a rare and disabling disease for which early diagnosis and
effective therapy are critical. This revision and update of the global WAO/EAACI guideline on …

Hereditary angioedema (HAE) is a rare autosomal genetic disease for which there are
currently nine FDA-approved drugs. This review summarizes drug treatments for HAE based …

Hereditary angioedema (HAE) is a rare disease characterized by sudden and often
unprovoked episodes of swelling that can be potentially life-threatening when it involves the …

Background Symptoms of hereditary angioedema (HAE) often first occur during childhood,
and HAE attacks in children can be severe and substantially affect health-related quality of …

Hereditary angioedema (HAE) is a rare disease caused by mutations in the SERPING1
gene. This results in deficient or dysfunctional C1 esterase inhibitor (C1-INH) and affects …

Aim: With no head-to-head studies comparing the effectiveness of lanadelumab and
berotralstat for prevention of hereditary angioedema (HAE) attacks, this network meta …

Introduction Hereditary angioedema (HAE) is a rare genetic disorder characterized by
recurrent edema and predominantly caused by the dysregulation of the kinin-kallikrein …

Background Hereditary angioedema (HAE) is associated with a substantial disease burden.
Lanadelumab reduced the HAE attack rate during 132 weeks of follow-up in the HELP open …

Background Hereditary angioedema (HAE) is an autosomal dominant inherited disease in
which patients suffer from local attacks primarily affecting skin and gastrointestinal tract, and …

Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent
episodes of skin/mucosal swelling, and/or attacks of severe abdominal pain when it affects …